Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
暂无分享，去创建一个
H. Einsele | G. Papanicolaou | M. Boeckh | J. Lipton | P. Ljungman | F. Marty | A. Ferrant | R. Chemaly | L. Strasfeld | J. Maertens | M. Schmitt | Jo-Anne H. Young | S. Villano | D. Winston | T. Rodriguez | Hongzi Chen